Objective. Analyze the use of endoscopic hemostasis methods by endoscopists in patients with gastroduodenal bleeding in hospitals of different levels. Material and methods. A survey of endoscopists working in hospitals providing emergency medical care of surgical profile, including patients with ulcerative gastroduodenal bleeding, was conducted. Endoscopic hemostasis is the leading method in the treatment of patients in this category. In most cases, the success of endoscopic hemostasis depends on the choice of the method or its combination, and avoids relapse and surgical treatment. Results. Analysis of the survey results showed that all patients with ulcerative gastroduodenal bleeding undergo endoscopic hemostasis, regardless of the level of the medical institution and the experience of the endoscopist. In 100% of cases, preference is given to injection hemostasis and, if necessary, its combination with other methods. The unanimous opinion on the need to conduct a control study after endoscopic hemostasis was confirmed. Conclusion. Timely choice of management tactics for patients with ulcerative gastroduodenal bleeding and the method of endoscopic hemostasis or its combination can significantly reduce the risk of relapse and surgical treatment.
8 February 2025 in Journal of Volgograd State Medical University
Internal abdominal paracecal hernias are a rare surgical pathology. The authors present 4 own observations of complicated paracecal hernias of different localization and clinical picture, both acute intestinal obstruction and acute appendicitis.
ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка результатов превентивного стентирования главного протока поджелудочной железы (ГППЖ) у пациентов после эндоскопических транспапиллярных вмешательств в профилактике острого постманипуляционного панкреатита (ОПМП). МАТЕРИАЛ И МЕТОДЫ В период с 2015 по 2021 г. выполнили 1135 эндоскопических транспапиллярных вмешательств. По поводу доброкачественной патологии (папиллостеноз, холедохолитиаз, аденомы большого сосочка двенадцатиперстной кишки (БС ДПК), стриктуры общего желчного протока) выполнено 879 (77,4%) вмешательств и 256 (22,6%) манипуляций по поводу злокачественных заболеваний панкреатодуоденальной зоны (рак головки поджелудочной железы, БС ДПК, желчного пузыря, метастазов в лимфатические узлы ворот печени). РЕЗУЛЬТАТЫ Факторами риска развития ОПМП являются женский пол, молодой возраст, трудности при канюляции БС ДПК, атипичная папиллосфинктеротомия. Доказано, что у пациентов, которым выполнялось превентивное стентирование ГППЖ, риск развития ОПМП уменьшается с 15,9 до 4,3%. ЗАКЛЮЧЕНИЕ Превентивное стентирование ГППД как завершающий этап транспапиллярного эндоскопического вмешательства, позволяет достигнуть высокого профилактического эффекта в отношении острого постманипуляционного панкреатита.
23 April 2023 in Journal of Volgograd State Medical University
To evaluate the effectiveness of preventive measures in relation to the development of acute postmanipulatory pancreatitis in patients after endoscopic transpapillary interventions. Materials and methods: In the period from September 2021 to June 2022, 73 endoscopic transpapillary interventions for benign pathology and malignant pathology were performed in patients. The analysis of the frequency of the development of acute postmanipulatory pancreatitis in different time intervals in patients who underwent prophylaxis in various ways, depending on the combination of risk factors. Results and discussion: Acute postmanipulatory pancreatitis developed in 2 (3.7 %) patients who underwent transpapillary interventions in various volumes for complicated cholelithiasis. Drug prophylaxis of acute postmanipulatory pancreatitis was carried out in the preoperative period for all patients. Preventive stenting of the main pancreatic duct was performed in the presence of a combination of risk factors. Conclusion: The analysis of the results of endoscopic transpapillary interventions made it possible to identify the most significant measures that allowed to reduce the number of developed to 3 acute postmanipulatory pancreatitis to 3.7 % and thereby increase the safety of transpapillary interventions.